Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$0.53 - $0.93 $170,397 - $298,999
-321,505 Reduced 9.23%
3,160,537 $1.83 Million
Q4 2023

Feb 13, 2024

BUY
$0.63 - $1.14 $86,231 - $156,038
136,876 Added 4.09%
3,482,042 $2.89 Million
Q3 2023

Nov 13, 2023

BUY
$1.12 - $1.88 $55,779 - $93,629
49,803 Added 1.51%
3,345,166 $3.78 Million
Q2 2023

Aug 11, 2023

BUY
$1.31 - $2.04 $696,280 - $1.08 Million
531,512 Added 19.23%
3,295,363 $5.27 Million
Q1 2023

May 15, 2023

BUY
$1.45 - $2.95 $61,759 - $125,649
42,593 Added 1.57%
2,763,851 $4.2 Million
Q4 2022

Feb 13, 2023

BUY
$2.02 - $3.25 $318,661 - $512,697
157,753 Added 6.15%
2,721,258 $6.53 Million
Q3 2022

Nov 14, 2022

BUY
$1.96 - $3.14 $173,271 - $277,588
88,404 Added 3.57%
2,563,505 $5.26 Million
Q2 2022

Aug 12, 2022

BUY
$1.3 - $2.64 $391,960 - $795,981
301,508 Added 13.87%
2,475,101 $4.8 Million
Q1 2022

May 13, 2022

SELL
$2.35 - $3.47 $167,359 - $247,122
-71,217 Reduced 3.17%
2,173,593 $5.35 Million
Q4 2021

Feb 08, 2022

BUY
$2.92 - $5.74 $389,127 - $764,929
133,263 Added 6.31%
2,244,810 $7.23 Million
Q3 2021

Nov 15, 2021

BUY
$4.98 - $6.63 $346,747 - $461,633
69,628 Added 3.41%
2,111,547 $11.1 Million
Q2 2021

Aug 13, 2021

BUY
$2.56 - $5.49 $914,560 - $1.96 Million
357,250 Added 21.21%
2,041,919 $11.2 Million
Q1 2021

May 12, 2021

SELL
$2.69 - $5.25 $146,443 - $285,810
-54,440 Reduced 3.13%
1,684,669 $4.58 Million
Q4 2020

Feb 11, 2021

SELL
$3.17 - $4.49 $58,381 - $82,692
-18,417 Reduced 1.05%
1,739,109 $5.53 Million
Q3 2020

Nov 16, 2020

BUY
$2.98 - $5.2 $1.04 Million - $1.81 Million
348,816 Added 24.76%
1,757,526 $7.03 Million
Q2 2020

Aug 14, 2020

BUY
$2.29 - $4.24 $74,724 - $138,355
32,631 Added 2.37%
1,408,710 $5.54 Million
Q1 2020

May 14, 2020

BUY
$1.92 - $4.39 $100,350 - $229,447
52,266 Added 3.95%
1,376,079 $3.37 Million
Q4 2019

Feb 14, 2020

BUY
$2.41 - $4.4 $101,518 - $185,345
42,124 Added 3.29%
1,323,813 $5.39 Million
Q3 2019

Nov 13, 2019

BUY
$2.17 - $3.14 $248,840 - $360,073
114,673 Added 9.83%
1,281,689 $3.31 Million
Q2 2019

Aug 13, 2019

BUY
$2.53 - $3.04 $26,977 - $32,415
10,663 Added 0.92%
1,167,016 $3.5 Million
Q1 2019

May 13, 2019

BUY
$2.51 - $3.73 $163,516 - $242,994
65,146 Added 5.97%
1,156,353 $3.43 Million
Q4 2018

Feb 12, 2019

SELL
$1.59 - $2.66 $123,543 - $206,682
-77,700 Reduced 6.65%
1,091,207 $2.6 Million
Q3 2018

Nov 14, 2018

BUY
$1.59 - $2.42 $259,818 - $395,447
163,408 Added 16.25%
1,168,907 $2.5 Million
Q2 2018

Sep 18, 2018

SELL
$2.26 - $4.65 $13,300 - $27,365
-5,885 Reduced 0.58%
1,005,499 $2.28 Million
Q2 2018

Aug 14, 2018

BUY
$2.26 - $4.65 $106,638 - $219,410
47,185 Added 4.89%
1,011,384 $2.3 Million
Q1 2018

May 09, 2018

BUY
$3.51 - $6.04 $129,964 - $223,643
37,027 Added 3.99%
964,199 $4.54 Million
Q4 2017

Feb 14, 2018

SELL
$3.26 - $4.78 $78,044 - $114,433
-23,940 Reduced 2.52%
927,172 $3.02 Million
Q3 2017

Nov 13, 2017

BUY
$3.48 - $4.44 $3.31 Million - $4.22 Million
951,112
951,112 $4.19 Million

Others Institutions Holding AGEN

About AGENUS INC


  • Ticker AGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 283,163,008
  • Market Cap $4.73B
  • Description
  • Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...
More about AGEN
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.